Management of Inborn Errors of Metabolism: Current Strategies and Future Directions
Journal of Clinical and Laboratory Research · 26.01.2026 · 09 (01) · 01-05
DOI: 10.31579/2768-0487/200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Laboratory Research, online erschienen am 26.01.2026. Verfasst von Okezie und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Inborn errors of metabolism (IEMs) are a diverse collection of single-gene abnormalities that interfere with metabolic pathways and can lead to multisystem disease throughout an individual's life. Management strategies have transitioned from primarily supportive care and dietary modification to disease-modifying interventions, encompassing enzyme replacement therapy (ERT), substrate reduction, pharmacological chaperones, organ and haematopoietic transplantation, cystostatic/cofactor therapies, and rapidly advancing genetic therapies, including gene addition, haematopoietic stem cell gene therapy, and genome editing. The extension of newborn screening, the development of better diagnostic tools (such tandem mass spectrometry and next-generation sequencing), and a better understanding of how diseases progress have all made it possible to start treatment earlier and give patients more personalised care. There are still problems, such as different levels of effectiveness in different organ systems (particularly the CNS), high treatment costs, restricted access around the world, and ethical and regulatory challenges for new treatments. Future directions encompass targeted gene correction, enhanced safety and efficacy of gene delivery technologies, optimised intervention timing (pre-/neonatal), improved blood-brain barrier (BBB) delivery, and worldwide implementation strategies to assure equity.
Zitieren
APA
Okezie, O.A, Onyeka, O, Iwuamadi, O.C, Obasi, M, Oparaocha, D.G, Uzor, S, & *, N. J. (2026). Management of Inborn Errors of Metabolism: Current Strategies and Future Directions. Journal of Clinical and Laboratory Research, 09(01), 01-05. https://doi.org/10.31579/2768-0487/200
Vancouver
Okezie, O.A, Onyeka, O, Iwuamadi, O.C, et al. Management of Inborn Errors of Metabolism: Current Strategies and Future Directions. Journal of Clinical and Laboratory Research. 2026;09(01):01-05. doi:10.31579/2768-0487/200
BibTeX
@article{Okezie2026,
author = {Okezie and O.A and Onyeka and O and Iwuamadi and O.C and Obasi and M and Oparaocha and D.G and Uzor and S and *, Nnodim JK},
title = {Management of Inborn Errors of Metabolism: Current Strategies and Future Directions},
journal = {Journal of Clinical and Laboratory Research},
year = {2026},
volume = {09},
number = {01},
pages = {01--05},
doi = {10.31579/2768-0487/200}
}
EUVIMED